Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04900597 · ClinicalTrials.gov registry record · NA
Effect of Blenderized Enteral Tube Feeds on Pediatric Upper Gastrointestinal Tract Physiology
A NA study of Enteral Feeding Intolerance, sponsored by Boston Children's Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 45
- Enrollment target
- 1
- Study location
NCT04900597: Recruiting NA study of Enteral Feeding Intolerance, sponsored by Boston Children's Hospital.
NCT04900597 is a NA study of Enteral Feeding Intolerance that is actively recruiting participants, run by Boston Children's Hospital. The registered enrollment target is 45 participants, below the 78-participant average among 3 other Enteral Feeding Intolerance trials with a reported enrollment target (42% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04900597, a NA study of Enteral Feeding Intolerance, is actively recruiting participants, sponsored by Boston Children's Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
- 1
- Study location
Study Summary
Blenderized diets consist of a wide range of table foods such as fruits, vegetables, meat and legumes, pureed in a blender and administered via gastrostomy tube. In a recent study, the investigators reported that children receiving blenderized feeds via gastrostomy had fewer total admissions and respiratory admissions, total emergency room visits, and improved gastrointestinal symptom scores compared to those fed formula. The goal of this project is to understand how these diets affect gastroesophageal reflux burden.
Primary Outcome
Number of total reflux episodes (acid and non-acid) by impedance
Conditions Studied
Interventions
- OTHER Elecare Jr
- OTHER Nourish
- OTHER Real Foods Blends
Study Locations (1)
Massachusetts
- Boston Children's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2021-08-01 |
| Est. Completion | 2025-12 |
| Phase | NA |
What NCT04900597 shows while recruiting
NCT04900597 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 78-participant average among 3 other Enteral Feeding Intolerance trials with a reported enrollment target (42% lower).
The record links to 1 condition, with Enteral Feeding Intolerance appearing as the primary indexed condition, and to 3 interventions - of which Elecare Jr is the first listed.
NCT04900597 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04900597 about?
NCT04900597 is a clinical study titled "Effect of Blenderized Enteral Tube Feeds on Pediatric Upper Gastrointestinal Tract Physiology". Blenderized diets consist of a wide range of table foods such as fruits, vegetables, meat and legumes, pureed in a blender and administered via gastrostomy tube. In a recent study, the investigators reported that children receiving blenderized feeds via gastrostomy had fewer total admissions and res...
What is the current status of trial NCT04900597?
This trial is currently recruiting. It is a NA study. The enrollment target is 45 participants. The study started on 2021-08-01. Estimated completion is 2025-12.
What conditions does trial NCT04900597 study?
This clinical trial studies the following conditions: Enteral Feeding Intolerance.
What interventions are being tested in trial NCT04900597?
The interventions under investigation include: Elecare Jr (OTHER), Nourish (OTHER), Real Foods Blends (OTHER).
Who is sponsoring clinical trial NCT04900597?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04900597 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Enteral Feeding Intolerance
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI